Looking to the Future of FCS
Personalized Cancer Treatment – Thanks to rapid advancements in precision medicine, FCS oncologists are able to personalize cancer treatment based on each patient’s specific and unique molecular structure. Our in-house next-generation molecular testing capabilities and precision oncology system, FCS PRECISE™, optimize the delivery and integration of molecular data and decision support capabilities more completely than ever before.
Advanced, New Therapies and Technology – Early and late-phase studies conducted with participation from our three Drug Development Units and clinics across our practice continue to reveal new discoveries in the use of targeted immunotherapies, radiopharmaceuticals, precision medicine and molecular-based treatments that effectively kill, block or inhibit the growth of cancer cells. The impact of our work is advancing the course of care for cancer patients on a global scale.
Leaders in Cancer Care – We are proud of our tremendous track record and the momentum we are creating at the forefront of science and research. FCS remains successful in building the fundamental infrastructure that includes innovative technologies, the finest clinical experts and critical partnerships that will carry us far into the future.